Key references: Dabigatran poisoning

Australian Government, Department of Health, Therapeutic Goods Administration. PRAXBIND idarucizumab (rch) 50mg/ml solution for injection/infusion vial [Public summary ARTG 237761]. Canberra, ACT: Commonwealth of Australia; [2016]. https://www.tga.gov.au/resources/artg/237761
Clinical Excellence Commission. Non-vitamin K antagonist oral anticoagulants (NAOC) guidelines, updated July 2017. Sydney: Clinical Excellence Commission; 2017. http://www.cec.health.nsw.gov.au/patient-safety-programs/medication-safety/high-risk-medicines/anticoagulants
Levine M, Beuhler MC, Pizon A, Cantrel FL, Spyres MB, LoVecchio F, et al. Assessing bleeding risk in patients with intentional overdoses of novel antiplatelet and anticoagulant medications. Ann Emerg Med 2018;71(3):273–8. https://www.ncbi.nlm.nih.gov/pubmed/29032872